Insider trade

Elanco (ELAN): CEO received 117.99 units

Jeffrey N Simmons, CEO at Elanco, reported a grant / award of 117.99 units.

117.99
Derivative units · @ $23.47
Traded
Jan 9, 2026
Filed
Jan 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 5, 2025Company filing · Form 8-K · Restructuring, Reg FDAnnounced job cuts, closures or a restructuring, and shared information with investors“On December 5, 2025, the Board of Directors of Elanco Animal Health Incorporated (the “Company”) authorized a restructuring plan with respect to its workforce (the “Restructuring Plan”) to support margin expansion, optimize the Company’s footprint, and further invest in innovation.”
  2. Dec 11, 2025Insider · 2 peopleInsiders: 2 purchases (~$629K)
  3. Dec 12, 2025Insider · 3 insiders in a week, 7th time since 2018Director purchased ~$213K of ELAN shares in the open market

What came next

  1. Feb 24, 2026Company filing · Form 8-K · ResultsReported its results
  2. May 6, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Elanco

For Elanco, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ELAN page.

Other recent filings by Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR

The full history of Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR is on the profile page.

How this filing works

Explore the data

Common questions

Which Elanco (ELAN) insider traded, and how much?

Jeffrey N Simmons, CEO at Elanco, reported a grant / award of 117.99 units. At $23.47.

When did it happen, and when was it made public?

Traded: Jan 9, 2026. Filed: Jan 13, 2026. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Elanco recently?

For Elanco, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the ELAN page.

Does this mean ELAN stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Elanco

Everything OQRO holds on this company is on its ELAN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data